Granite Shares Advisors LLC Abb Vie Inc. Transaction History

Granite Shares Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $24,779 - $30,836	-187 Reduced 3.53%	5,107 $688,000
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $16,630 - $19,152	-115 Reduced 2.13%	5,294 $843,000
Q4 2022 Jan 26, 2023	SELL	$138.31 - $165.87 $143,704 - $172,338	-1,039 Reduced 16.11%	5,409 $0
Q3 2022 Oct 14, 2022	SELL	$134.21 - $153.93 $98,375 - $112,830	-733 Reduced 10.21%	6,448 $865,000
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $100,737 - $128,070	-732 Reduced 9.25%	7,181 $1.1 Million
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $99,908 - $123,958	-757 Reduced 8.73%	7,913 $1.28 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $931,418 - $1.18 Million	8,670 New	8,670 $1.17 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Shares Advisors LLC with notifications on news.